Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes

Thrombocytopenia is a known potential side effect of hemodialysis, however, it is rarely seen in patients who undergo hemodialysis using biocompatible membranes. This case demonstrates hemodialysis-associated thrombocytopenia with use of biocompatible dialysis membranes that expose blood directly to...

Full description

Saved in:
Bibliographic Details
Main Authors: Kathryn B. Muir, Clifford D. Packer
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2012/358024
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567978626908160
author Kathryn B. Muir
Clifford D. Packer
author_facet Kathryn B. Muir
Clifford D. Packer
author_sort Kathryn B. Muir
collection DOAJ
description Thrombocytopenia is a known potential side effect of hemodialysis, however, it is rarely seen in patients who undergo hemodialysis using biocompatible membranes. This case demonstrates hemodialysis-associated thrombocytopenia with use of biocompatible dialysis membranes that expose blood directly to polysulfone. The thrombocytopenia resolved in this patient when the dialysis membrane was changed to a biocompatible model with a polyethylene glycol barrier layer preventing direct interaction between patient blood and polysulfone. The calculated Naranjo ADR score of 9 indicates a highly probable adverse reaction.
format Article
id doaj-art-f2e9907ea8cc4b7f9a95f6b43f063ba3
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-f2e9907ea8cc4b7f9a95f6b43f063ba32025-02-03T01:00:02ZengWileyCase Reports in Medicine1687-96271687-96352012-01-01201210.1155/2012/358024358024Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible MembranesKathryn B. Muir0Clifford D. Packer1School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USASchool of Medicine, Case Western Reserve University, Cleveland, OH 44106, USAThrombocytopenia is a known potential side effect of hemodialysis, however, it is rarely seen in patients who undergo hemodialysis using biocompatible membranes. This case demonstrates hemodialysis-associated thrombocytopenia with use of biocompatible dialysis membranes that expose blood directly to polysulfone. The thrombocytopenia resolved in this patient when the dialysis membrane was changed to a biocompatible model with a polyethylene glycol barrier layer preventing direct interaction between patient blood and polysulfone. The calculated Naranjo ADR score of 9 indicates a highly probable adverse reaction.http://dx.doi.org/10.1155/2012/358024
spellingShingle Kathryn B. Muir
Clifford D. Packer
Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
Case Reports in Medicine
title Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
title_full Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
title_fullStr Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
title_full_unstemmed Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
title_short Thrombocytopenia in the Setting of Hemodialysis Using Biocompatible Membranes
title_sort thrombocytopenia in the setting of hemodialysis using biocompatible membranes
url http://dx.doi.org/10.1155/2012/358024
work_keys_str_mv AT kathrynbmuir thrombocytopeniainthesettingofhemodialysisusingbiocompatiblemembranes
AT clifforddpacker thrombocytopeniainthesettingofhemodialysisusingbiocompatiblemembranes